CJC-1295 / Ipamorelin
A pulsatile GH support protocol using the no-DAC form of CJC-1295.
Not FDA-approved · Investigational use
Pulses, not a plateau.
CJC-1295 (in the no-DAC form) is a modified version of the active fragment of growth-hormone-releasing hormone (GHRH). It signals the pituitary to release a growth hormone pulse, then clears within a few hours. Ipamorelin is a selective ghrelin-receptor agonist that triggers a parallel pulse on the same pituitary cells.[1] Together, they produce a larger, sharper GH release than either on its own.
There are two versions of CJC-1295. The DAC version has an albumin-binding tail that extends its half-life to roughly 6 to 8 days, producing a sustained, non-pulsatile elevation of GH and IGF-1.[2] The no-DAC version clears in about half an hour, which keeps the dosing closer to your body’s natural pulsatile pattern.
We use the no-DAC form on purpose. Pulsatile GH release is the physiology your body already uses, mostly during deep sleep. A sustained DAC-driven floor of GH is a different pharmacologic state, with theoretical concerns about receptor downregulation and disrupted feedback. Whether pulsatile is meaningfully better than sustained at wellness doses isn’t settled by head-to-head trials, but the mechanistic argument is the reason we choose no-DAC.
What patients notice.
- Deeper sleep and quicker time to fall asleep, often noticed first
- Better recovery between training sessions
- Reported improvements in body composition over months, not days
- Skin quality changes in some patients
- Subjective sense of more steady morning energy
Response is individual; we don’t guarantee outcomes.
The protocol, plainly.
Dosing summary
Bedtime dosing aligns with the body’s natural overnight GH pulse. The 5-on / 2-off rhythm gives the pituitary regular off-days. The 12-on / 4-off cycle preserves responsiveness rather than pushing the system continuously.
Doses are adjusted based on what you’re noticing in training, sleep, and recovery. The cycle structure is the main lever; we adjust if a cycle isn’t doing what you expected, not on a fixed timeline.
Patients who don’t get adequate sleep, who under-eat protein, or who skip training sessions usually don’t see much from this protocol. The peptide layer assumes the basics are already in place.
The patient who fits.
Most patients who pursue this protocol are adults 35 and older who train consistently and have already addressed sleep, protein, and any hormone deficits. They’re looking for a layer on top of a working baseline, not a substitute for one.
We talk through any history of cancer, pituitary disease, or diabetes before starting. This is a months-long commitment, not a short cycle.
Considerations before starting
- Not appropriate with active or recent cancer, or with pituitary disease
- Avoid in pregnancy and breastfeeding. No safety data.
- May affect glucose tolerance. Worth knowing if you have diabetes or pre-diabetic markers.
- Reported effects include injection-site reactions, transient flushing, and mild headaches in some users
What this is often used alongside.
Most patients on CJC-1295 / ipamorelin are also working on the basics elsewhere. This protocol is often used to supplement other services like testosterone replacement, medical weight management, and the GLP-1 program.
CJC-1295 / Ipamorelin are not FDA-approved drugs. The peptides used in this protocol are sourced from specialty peptide distributors that perform Certificate of Analysis (COA) testing on every lot to confirm identity, purity, and concentration, and that operate under the regulatory and quality standards applicable to their industry. They have not been evaluated by the FDA for the diagnosis, treatment, cure, or prevention of any disease, and we treat their use as investigational and as part of an individualized wellness plan. The information on this page reflects published research, clinical experience, and what patients have reported. It is not a medical claim or a guarantee of any outcome.
Questions we get about CJC-1295 / Ipamorelin
Answers from Dr. Oliver Morris, Medical Director at Olympia Aesthetics & Wellness in Palm Harbor.
Is CJC-1295 / Ipamorelin FDA approved?
No. Neither CJC-1295 nor ipamorelin is an FDA-approved drug, and neither has been evaluated by the FDA for the diagnosis, treatment, cure, or prevention of any disease. We treat their use as investigational and as part of an individualized wellness plan. That doesn't mean unsupervised. The peptides in this protocol come from specialty peptide distributors that run Certificate of Analysis testing on every lot to confirm identity, purity, and concentration. Before anyone starts, we do a full intake and lab review, then decide together whether the protocol makes sense for you. At Olympia Aesthetics & Wellness in Palm Harbor, FL, it's prescribed and supervised by Dr. Oliver Morris, with follow-up built in. We don't guarantee outcomes, and we say so plainly.
Who can prescribe CJC-1295 / Ipamorelin?
Only a licensed medical provider can prescribe it, and even then it's prescribed as an investigational peptide rather than an FDA-approved drug. At Olympia, peptide therapy is overseen by Dr. Oliver Morris, a board-certified physician who reviews your history and labs before writing anything. That evaluation isn't a formality. We talk through any history of cancer, pituitary disease, or diabetes first, since the protocol isn't appropriate with active or recent cancer or with pituitary disease, and there's no safety data in pregnancy or breastfeeding. Follow-up monitoring continues through the program, with dosing adjusted based on how you're actually responding in sleep, training, and recovery. Anyone selling this without a prescription and an exam is skipping the part that keeps it safe.
How is CJC-1295 / Ipamorelin dosed?
It's a small subcutaneous injection at bedtime, taken five days on and two days off each week. The dose itself is provider-determined rather than a fixed number, because it's individualized and adjusted based on your response and follow-up labs. Bedtime timing lines up with your body's own overnight growth hormone pulse, and the two off-days each week give the pituitary regular breaks. A typical cycle runs 12 weeks on, then a 4-week break before repeating, which preserves responsiveness instead of pushing the system continuously. Injections go into the abdomen. Most patients notice sleep changes in the first few weeks; body composition shifts, when they happen, usually show up around weeks 8 to 12. These peptides aren't FDA-approved, and the protocol assumes sleep, protein, and consistent training are already in place.
Continue the Conversation
If your training, sleep, and recovery have all shifted and you’ve already addressed the basics, a consultation is the right place to start. We’ll talk through your goals and decide together whether this protocol is appropriate for you.
Schedule a Consultation
Expert provider-led care.
Medically reviewed
Reviewed by Dr. Oliver Morris, Medical Director at Olympia Aesthetics & Wellness. Last reviewed May 5, 2026. This page reflects published research and clinical experience; it is not a guarantee of any outcome.
References
- Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology. 1998. PubMed 9849822
- Teichman SL, Neale A, Lawrence B, et al. Prolonged stimulation of growth hormone and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. Journal of Clinical Endocrinology & Metabolism. 2006. PubMed 16352683
What "not FDA-approved" actually means
Patients ask this before anything else, and it deserves a direct answer. Neither CJC-1295 nor ipamorelin is an FDA-approved drug. Neither has been evaluated by the FDA for the diagnosis, treatment, cure, or prevention of any disease. We treat both as investigational, used as part of an individualized wellness plan rather than as a treatment for a diagnosed condition.
What that phrase does not mean is illegal, and it does not automatically mean unsafe. It means no company has taken these two peptides through the long, expensive approval pathway that ends with a labeled indication for a specific disease. Plenty of compounds used in wellness medicine sit in exactly that spot. Approval status tells you something about a regulatory process. By itself, it tells you very little about how carefully a given protocol is being run.
Responsible use has several moving parts, and all of them matter. A licensed provider evaluates you first, which for this protocol means talking through any history of cancer, pituitary disease, or diabetes before a prescription is written. The peptides come from specialty peptide distributors that perform Certificate of Analysis testing on every lot to confirm identity, purity, and concentration. Dosing is provider-determined rather than a number pulled off a forum, and it gets adjusted based on what you are actually noticing in sleep, training, and recovery.
So the question worth asking is not only whether something is FDA-approved. It is who evaluated you, where the vial came from, and who is watching what happens next. The version to avoid is the unprescribed vial ordered online, with no exam, no lab review, and no way to verify what is inside it. At Olympia Aesthetics and Wellness in Palm Harbor, this protocol is prescribed and supervised by Dr. Oliver Morris, Medical Director, with follow-up built in. We don't guarantee outcomes, and we say so plainly.
Questions patients ask about cjc 1295 ipamorelin
Answers from Dr. Oliver Morris, Medical Director at Olympia Aesthetics & Wellness in Palm Harbor.
Is CJC-1295 / Ipamorelin FDA approved?
No. Neither CJC-1295 nor ipamorelin is an FDA-approved drug, and neither has been evaluated by the FDA for the diagnosis, treatment, cure, or prevention of any disease. We treat both as investigational and use them as part of an individualized wellness plan, not as a treatment for a diagnosed condition. That status is worth understanding rather than glossing over. It also doesn't describe how the protocol is actually run here. The peptides come from specialty peptide distributors that perform Certificate of Analysis testing on every lot to confirm identity, purity, and concentration. Before anyone starts, we do a full intake and lab review and decide together whether the protocol makes sense for you. At Olympia Aesthetics and Wellness in Palm Harbor, it's prescribed and supervised by Dr. Oliver Morris, Medical Director, with follow-up built in. We don't guarantee outcomes, and we won't pretend otherwise.
Can I just buy CJC-1295 and ipamorelin online instead?
You'll find plenty of vials sold that way, and we would steer you away from all of them. Anything sold without a prescription and without an exam skips the part that keeps this reasonably safe. There is no way for you to confirm what is actually in the vial, how pure it is, or whether it was ever sterile. The peptides used here are sourced from specialty peptide distributors that run Certificate of Analysis testing on every lot for identity, purity, and concentration. Just as important, someone reviews your history first. This protocol is not appropriate with active or recent cancer or with pituitary disease, and it may affect glucose tolerance, which matters if you have diabetes or pre-diabetic markers. A website is not asking you any of that. A real evaluation and a real prescription are what separate a protocol from a gamble.
Why do you use the no-DAC version of CJC-1295?
There are two versions, and the difference is how long the molecule sticks around. The DAC version carries an albumin-binding tail that stretches its half-life to roughly six to eight days, producing a sustained, non-pulsatile elevation of growth hormone and IGF-1. The no-DAC version clears in about half an hour. That short window keeps dosing closer to the pulsatile pattern your body already uses, mostly during deep sleep. A sustained floor of growth hormone is a different pharmacologic state, with theoretical concerns about receptor downregulation and disrupted feedback. Is pulsatile meaningfully better than sustained at wellness doses? Head-to-head trials haven't settled that question. The mechanistic argument is honestly the reason we chose the no-DAC form, and we would rather tell you that than dress it up as proven.
How long before I notice anything?
Sleep usually moves first. Most patients describe falling asleep faster and sleeping deeper within the first few weeks. Better recovery between training sessions tends to follow. Body composition changes, when they happen, show up around weeks eight to twelve, which is why we run a twelve-week cycle before a four-week break rather than judging things at week three. Some patients also report skin quality changes and a steadier sense of morning energy. Response is individual, and we don't guarantee outcomes. One honest caveat: patients who aren't sleeping enough, who under-eat protein, or who skip training sessions usually don't get much from this protocol. The peptide layer assumes the basics are already in place. If a cycle isn't doing what you expected, we revisit it rather than waiting out the calendar.
Why is the injection at bedtime, and why five days on and two days off?
Both choices are about working with your own rhythm instead of overriding it. Growth hormone is released in pulses, and the largest ones happen overnight during deep sleep. A bedtime subcutaneous injection into the abdomen lines up with that natural pulse. The five-on, two-off pattern gives the pituitary regular off-days rather than steady, uninterrupted signaling. The twelve-weeks-on, four-weeks-off cycle does the same thing on a longer scale, with the goal of keeping the system responsive instead of pushing it continuously. Cycle structure is the main lever we adjust, along with dose, which is provider-determined for each person rather than a fixed number off a chart. Adjustments come from what you are reporting in sleep, training, and recovery, not from a set schedule.
Who shouldn't do this protocol?
We talk through medical history before anything gets prescribed, and a few things rule it out. It is not appropriate with active or recent cancer, or with pituitary disease. We avoid it in pregnancy and breastfeeding, where there is no safety data at all. It may affect glucose tolerance, so if you have diabetes or pre-diabetic markers that becomes a real part of the conversation rather than a footnote. Reported effects include injection-site reactions, transient flushing, and mild headaches in some users. Beyond the medical screening, there is a practical filter. This is a months-long commitment, and it works best as a layer on top of consistent training, adequate protein, decent sleep, and any hormone deficits already addressed. If those aren't in place, we would rather fix them first.
